What will happen to healthcare in the United States when the election is over, the Supreme Court has heard arguments to declare the ACA unconstitutional, the coronavirus is still infecting Americans, and the political landscape is a little less uncertain? No one knows for sure, but Dr. Kent Bottles certainly has his opinions and provides them by looking into his crystal ball and analyzing perspectives from key opinion leaders in the field. As Kent likes to quote, "Prediction is very difficult, especially if it's about the future" (Nobel Physics laureate Nils Bohr) and "It is far better to foresee even without certainty than not to foresee at all" (Henri Poincare). In this webinar Kent covers:
1. How the ACA will change in 2021.
2. How the COVID-19 crisis will transform healthcare and society in the future.
3. How the new Congress will legislate in the healthcare arena.
4. How the new political landscape will affect hospitals, doctors, patients, and pharmaceutical companies.
The problems facing the health industry are too complex for any one organization to solve alone. Improving health outcomes, access and affordability requires collaboration and coordination from diverse sectors, including life sciences, healthcare providers, payers, public health and services, and community resources. Developing the innovative partnerships and the leadership necessary to address issues like where to invest in R&D, how to implement technology solutions, pathways for clinical treatments, best practices in data sharing, etc. is crucial for success. This presentation focuses on the opportunity pharmaceutical leaders have in leading the future health ecosystem by building collaborative partnerships that have the capacity to add tremendous value to promoting health and wellness throughout the globe. We offer strategies for building and demonstrating health ecosystem leadership through case studies and practical learning applications that leaders can implement back on the job, with their teams and their organizations.
A funny thing is happening among senior leadership teams in health systems (and other sectors as well). More and more clients are telling us that multiple members of their senior leadership teams, starting with the CEO on down, could retire if they wanted to. Then they are quick to say “But of course, no one has any immediate plans to retire,--and that’s a good thing because we really don’t have any real successors.” That statement is often followed by some nervous laughter, and maybe someone muttering “We really need to do something about a succession plan.” Then it’s usually onto the next subject.
Disruption continues to challenge our industry. Now more than ever boards are in a unique position to advise leadership on how to best respond to the rapidly changing work environment resulting from the pandemic. Like many of our clients, you may be wondering if you have the right board in place to guide your organization into the future of work. The key to creating a meaningful board starts with assessing and selecting key success factors.
At TLD Group, we believe that leaders plays an important role in advancing conversations around equity, diversity, and inclusion from awareness to action. Leaders have the platform and influence to ignite the dialogue that leads to meaningful change. In this session of our Equity, Diversity, and Inclusion series we interview Dr. Ronald L. Copeland, Senior Vice President of National Diversity and Inclusion Strategy and Policy and Chief Equity, Inclusion, and Diversity Officer for Kaiser Permanente, who has dedicated his platform to doing just that.
During the conversation, led by and TLD Group Advisory Board Chair, Bob Sachs, PhD, they explore Kaiser Permanente’s views on the impact of racial disparities and social determinants on health, and the organization's long term commitment to access to care for all.
Since Dr. Bottles’ first webinar in our COVID-19 series in April on Lessons Gleaned to Inspire Healthcare Transformations, we have learned so much about the pandemic, how to combat it, and its widespread impact on life as we know it. In this webinar, Dr. Bottles reviews the current status of COVID-19 including: The state of the US and global responses to the pandemic, vaccine development and distribution, testing and contact tracing, economic shutdown and other mitigation procedures, safety of children in public and private schools, progress in understanding the biology of the virus, and epidemiology.
It's no secret that the US health system is in desperate need of repair. Structural inequities such as housing and food insecurity, air and water pollution, and access to educational and economic opportunities — known to the medical community as social determinants have been linked to disparate health outcomes for years. However, never in recent history have we so acutely and rapidly felt their affects as we have during the COVID-19 pandemic. United around the common purpose to improve overall population health, industry leaders must harness their collective power and influence to champion changes that will benefit the health of our nation.
Improving population health hinges on the ability of organizations from diverse sectors to collaborate. In a recent survey conducted by ORC International and Change Healthcare, which included 120 payers across the country who worked with providers to integrate value-based models, nearly a quarter of them reported cost savings as high as 7.5%. Almost 80% of these payer organizations also cited the quality of care improved, while 64% reported better provider relationships, and 73% reported improvements in patient engagement. A Commonwealth Fund analysis demonstrated that value-based models lead to fewer emergency hospital visits and downstream cost efficiencies relative to similar markets.
